Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges

Author:

Zheng Haiqiong,Chen Yijin,Luo Qian,Zhang Jie,Huang Mengmeng,Xu Yulin,Huo Dawei,Shan Wei,Tie Ruxiu,Zhang Meng,Qian Pengxu,Huang HeORCID

Abstract

AbstractHuman pluripotent stem cells (hPSCs) have been suggested as a potential source for the production of blood cells for clinical application. In two decades, almost all types of blood cells can be successfully generated from hPSCs through various differentiated strategies. Meanwhile, with a deeper understanding of hematopoiesis, higher efficiency of generating progenitors and precursors of blood cells from hPSCs is achieved. However, how to generate large-scale mature functional cells from hPSCs for clinical use is still difficult. In this review, we summarized recent approaches that generated both hematopoietic stem cells and mature lineage cells from hPSCs, and remarked their efficiency and mechanisms in producing mature functional cells. We also discussed the major challenges in hPSC-derived products of blood cells and provided some potential solutions. Our review summarized efficient, simple, and defined methodologies for developing good manufacturing practice standards for hPSC-derived blood cells, which will facilitate the translation of these products into the clinic.

Funder

National Key Research and Development Program of China

Natural Science Foundation of China

Zhejiang Provincial Natural Science Foundation of China

Sanming Project of Medicine in Shenzhen

Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Developmental Biology

Reference203 articles.

1. Ackermann M, Haake K, Kempf H, Kaschutnig P, Weiss AC, Nguyen AHH, Abeln M, Merkert S, Kuhnel MP, Hartmann D, et al. A 3D iPSC-differentiation model identifies interleukin-3 as a regulator of early human hematopoietic specification. Haematologica. 2021;106(5):1354–67. https://doi.org/10.3324/haematol.2019.228064. https://www.ncbi.nlm.nih.gov/pubmed/323274.

2. Ackermann M, Kempf H, Hetzel M, Hesse C, Hashtchin AR, Brinkert K, Schott JW, Haake K, Kuhnel MP, Glage S, et al. Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections. Nat Commun. 2018;9(1):5088. https://doi.org/10.1038/s41467-018-07570-7. https://www.ncbi.nlm.nih.gov/pubmed/30504915.

3. Ackermann M, Rafiei Hashtchin A, Manstein F, Carvalho Oliveira M, Kempf H, Zweigerdt R, Lachmann N. Continuous human iPSC-macrophage mass production by suspension culture in stirred tank bioreactors. Nat Protoc. 2022;17(2):513–39. https://doi.org/10.1038/s41596-021-00654-7. https://www.ncbi.nlm.nih.gov/pubmed/35039668.

4. Adamo L, Naveiras O, Wenzel PL, McKinney-Freeman S, Mack PJ, Gracia-Sancho J, Suchy-Dicey A, Yoshimoto M, Lensch MW, Yoder MC, et al. Biomechanical forces promote embryonic haematopoiesis. Nature. 2009;459(7250):1131–5. https://doi.org/10.1038/nature08073. https://www.ncbi.nlm.nih.gov/pubmed/19440194.

5. Amabile G, Welner RS, Nombela-Arrieta C, D’Alise AM, Di Ruscio A, Ebralidze AK, Kraytsberg Y, Ye M, Kocher O, Neuberg DS, et al. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood. 2013;121(8):1255–64. https://doi.org/10.1182/blood-2012-06-434407. https://www.ncbi.nlm.nih.gov/pubmed/23212524.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3